SCHEMBL5340650

SCHEMBL5340650

Cc1c(Cl)cccc1S(=O)(=O)Nc1ccc2scc(C)c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
SLC40A1 Q9NP59 1/20 0.45
EDNRB P24530 2/20 0.44
EDNRA P25101 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP2A6 P11509 1/20 0.43
SLC22A12 Q96S37 2/20 0.43
GSPT1 P15170 1/20 0.43
DDB1 Q16531 1/20 0.43
CRBN Q96SW2 1/20 0.43
LMNA P02545 1/20 0.42
THRB P10828 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B1 P14061 2/20 0.42
HSD17B2 P37059 2/20 0.42
HIF1A Q16665 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5340610 0.80 HSD11B1 (0.50) HSD11B1MEN1KMT2ASLC40A1EDNRB
SCHEMBL618067 0.77 BRD4 (0.56) HSD11B1MEN1KMT2ASLC40A1EDNRB
SCHEMBL5345756 0.76 HSD11B1 (0.52) HSD11B1MEN1KMT2ASLC40A1EDNRB
SCHEMBL615643 0.75 ALDH1A1 (0.51) HSD11B1MEN1KMT2ASLC40A1EDNRB
SCHEMBL614790 0.75 PKM (0.56) HSD11B1MEN1KMT2ASLC40A1EDNRB
SCHEMBL10089752 0.75 PKM (0.68) HSD11B1MEN1KMT2ASLC40A1ALDH1A1
SCHEMBL7578851 0.75 HSD11B1 (0.58) HSD11B1MEN1KMT2ASLC40A1EDNRB
SCHEMBL5339044 0.74 PFKFB3 (0.45) HSD11B1MEN1KMT2ASLC40A1EDNRB
SCHEMBL613996 0.74 PKM (0.54) HSD11B1MEN1KMT2ASLC40A1EDNRB
SCHEMBL3768958 0.73 HSD11B1 (0.60) HSD11B1SLC40A1EDNRBEDNRAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 HSD11B1 6/4885MEN1 2978/4885KMT2A 1973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.